What is the optimal antithrombotic strategy in patients with atrial fibrillation having acute coronary syndrome or undergoing percutaneous coronary intervention?
Phase 4
Recruiting
- Conditions
- atrial fibrillationcoronary artery disease10011082
- Registration Number
- NL-OMON51815
- Lead Sponsor
- Sint Antonius Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1500
Inclusion Criteria
1. >=18 years of age
2. Undergoing PCI or presenting with ACS with elevated cardiac markers
(CK/CK-MB, troponin)
3. History of or newly diagnosed atrial fibrillation or flutter with a
long-term (>= 1 year) indication for OAC
Exclusion Criteria
1. Contra indication to edoxaban
2. < 3 months after any stroke
3. < 3 months after venous thrombo embolism
4. Mechanical heart valve prosthesis
5. Moderate to severe mitral valve stenosis
6. Intracardiac thrombus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method